The Patent Finder

Amgen Boulder Inc.

Also on record
Records under this name other than patents Amgen Boulder Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Amgen Boulder Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,858,409Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
Formerly held
Term ended
Term ended Feb 22, 2022 · USPTO record
Term endedTerm ended Feb 22, 2022USPTO record
US 6,541,620Nucleic acids encoding TNF inhibitor and method of production
Formerly held
Term ended
Ended no later than Apr 1, 2020 · USPTO record
Term endedEnded no later than Apr 1, 2020USPTO record
US 6,440,693TNF receptors, TNF binding proteins and DNAS coding for them
Term ended
Ended no later than Aug 27, 2019 · USPTO record
Term endedEnded no later than Aug 27, 2019USPTO record
US 6,417,158Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF
Term ended
Term ended Jul 9, 2019 · USPTO record
Term endedTerm ended Jul 9, 2019USPTO record
US 6,294,352TNF receptors, TNF binding proteins and DNAs coding for them
Term ended
Term ended Sep 25, 2018 · USPTO record
Term endedTerm ended Sep 25, 2018USPTO record
US 6,271,346TNF Receptors, TNF binding proteins and DNAs coding for them
Term ended
Term ended Aug 7, 2018 · USPTO record
Term endedTerm ended Aug 7, 2018USPTO record
US 6,221,675TNF receptors, TNF binding proteins and DNAs coding for them
Formerly held
Term ended
Term ended Apr 24, 2018 · USPTO record
Term endedTerm ended Apr 24, 2018USPTO record
US 6,143,866Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
Formerly held
Term ended
Term ended Nov 7, 2017 · USPTO record
Term endedTerm ended Nov 7, 2017USPTO record
US 6,869,925Inhibition of retrovirus infection
Formerly held
Lapsed on the fee record
Ended Mar 22, 2017 · USPTO record
Lapsed on the fee recordEnded Mar 22, 2017USPTO record
US 6,096,728Composition and method for treating inflammatory diseases
Formerly held
Term ended
Term ended Feb 7, 2017 · USPTO record
Term endedTerm ended Feb 7, 2017USPTO record
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited